References

    1. Beth B. DuPree, Michael J. Papez, Elaina Pirruccello, Audrey Hassenflug; Indian Journal of Surgery, Nov. 26, 2021; Association of Surgeons of India 2021. https://link.springer.com/article/10.1007/s12262-022-03306-6
    2. Bragg A, Candelaria R, Adrada B, Huang M, Rauch G, Santiago L, Scoggins M, Whitman G. Imaging of noncalcified ductal carcinoma in situ. J Clin Imaging Sci 2021;11:34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247756/
    3. National Cancer Institute. Cancer Stat Facts: Cancer of Any Site. Accessed January 15, 2023. https://seer.cancer.gov/statfacts/html/all.html
    4. Houssami N, Macaskill P, Marinovich ML, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. European Journal of Cancer. 2010;46:3219–3232.
    5. Metcalfe LN, Zysk AM, Yemul KS, Jacobs LK, Oker EE, Underwood HR, Thompson AM. Beyond the Margins-Economic Costs and Complications Associated With Repeated Breast-Conserving Surgeries. JAMA Surg. 2017 Nov 1;152(11):1084-1086. doi: 10.1001/jamasurg.2017.2661. PMID: 28768303; PMCID: PMC5831419
    6. Riba LA, Gruner RA, Fleishman A, James TA. Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer. Ann Surg Oncol. 2018;25(7):1904-1911. doi:10.1245/s10434-018-6351-7
    7. Baliski C, Bakos B. Patient reported outcomes following breast conserving surgery are improved by minimizing re-excisions and excessive breast tissue removal. Am J Surg. 2022;224(2):716-721. doi:10.1016/j.amjsurg.2022.03.008
    8. Moran MS, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Onc. 2014 Mar;21(3):704-16
    9. Perimeter B-Series OCT is not available for sale in the United States. CAUTION – Investigational device. Limited by U.S. law to investigational use.
    10. Orosco, R.K., Tapia, V.J., Califano, J.A. et al. Positive Surgical Margins in the 10 Most Common Solid Cancers. Sci Rep 8, 5686 (2018). https://doi.org/10.1038/s41598-018-23403-5
    11. DePolo, Jamie. Breast Cancer Surgical Margins. BreastCancer.org. 2023 Aug 25. https://www.breastcancer.org/pathology-report/breast-cancer-surgical-margins
    12. National Institutes of Health. (2019, May). Why Should I Participate in a Clinical Trial? U.S. Department of Health and Human Services. https://www.nih.gov/health-information/nih-clinical-research-trials-you/why-should-i-participate-clinical-trial
    13. Kim Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, Krause TM. Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery. Ann Surg Oncol. 2024 Feb 6. doi: 10.1245/s10434-024-14902-z. Epub ahead of print. PMID: 38319511. https://link.springer.com/article/10.1245/s10434-024-14902-z 
    14. Chakedis, J.M., Tang, A., Savitz, A. et al. Economic Impact of Reducing Reexcision Rates after Breast-Conserving Surgery in a Large, Integrated Health System. Ann Surg Oncol 29, 6288–6296 (2022). https://doi.org/10.1245/s10434-022-12127-6
    15. Matar-Ujvary R, Haglich K, Flanagan MR, Fuzesi S, Sevilimedu V, Nelson JA, Gemignani ML. The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q. Ann Surg Oncol. 2023 Sep;30(9):5341-5349.
    16. Deloitte. Value of patient experience: Hospitals with higher patient experience scores have higher clinical quality. Accessed October 4, 2024. https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-value-patient-experience-050517.pdf